HEADER MEMBRANE PROTEIN 14-APR-25 9UHU TITLE CRYO-EM STRUCTURE OF THE HUMAN ADENOSINE A2A RECEPTOR IN LIGAND FREE TITLE 2 STATE RESOLVED USING THE FUSION/CROSSLINKING STRATEGY COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENOSINE RECEPTOR A2A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: GREEN FLUORESCENT PROTEIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: AUTHOR STATED 2-3 IS GFP1-9.; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: GFP-CLAMP; COMPND 12 CHAIN: C; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADORA2A, ADORA2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: AEQUOREA VICTORIA; SOURCE 10 ORGANISM_TAXID: 6100; SOURCE 11 GENE: GFP; SOURCE 12 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 16 ORGANISM_TAXID: 32630; SOURCE 17 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS HUMAN ADENOSINE A2A RECEPTOR; FUSION/CROSSLINKING STRATEGY; MEMBRANE KEYWDS 2 PROTEIN., MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.C.HAN,M.H.LI REVDAT 1 28-OCT-26 9UHU 0 JRNL AUTH S.C.HAN,M.H.LI JRNL TITL CRYO-EM STRUCTURE DETERMINATION OF GPCRS WITH JRNL TITL 2 DISULFIDE-CROSSLINKED FUSION PROTEIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, PHENIX, RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.190 REMARK 3 NUMBER OF PARTICLES : 108918 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9UHU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 18-APR-25. REMARK 100 THE DEPOSITION ID IS D_1300058526. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : APO A2AR-GFP10-11:GFP1-9:GFP REMARK 245 -CLAMP COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 2 REMARK 465 ILE A 3 REMARK 465 MET A 4 REMARK 465 GLY A 5 REMARK 465 SER A 6 REMARK 465 CYS A 146 REMARK 465 GLY A 147 REMARK 465 GLN A 148 REMARK 465 PRO A 149 REMARK 465 LYS A 150 REMARK 465 GLU A 151 REMARK 465 GLY A 152 REMARK 465 LYS A 153 REMARK 465 ASN A 154 REMARK 465 HIS A 155 REMARK 465 SER A 156 REMARK 465 GLN A 157 REMARK 465 GLY A 158 REMARK 465 CYS A 159 REMARK 465 GLY A 160 REMARK 465 GLU A 161 REMARK 465 GLY A 162 REMARK 465 GLN A 163 REMARK 465 VAL A 164 REMARK 465 ALA A 165 REMARK 465 CYS A 166 REMARK 465 LEU A 167 REMARK 465 PHE A 168 REMARK 465 GLU A 169 REMARK 465 ASP A 170 REMARK 465 VAL A 171 REMARK 465 VAL A 307 REMARK 465 LEU A 308 REMARK 465 ARG A 309 REMARK 465 GLN A 310 REMARK 465 GLN A 311 REMARK 465 GLU A 312 REMARK 465 PRO A 313 REMARK 465 PHE A 314 REMARK 465 LYS A 315 REMARK 465 ALA A 316 REMARK 465 ALA A 317 REMARK 465 GLY A 318 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 THR B 3 REMARK 465 GLY C 158 REMARK 465 GLY C 159 REMARK 465 GLY C 160 REMARK 465 SER C 161 REMARK 465 GLY C 162 REMARK 465 GLY C 163 REMARK 465 GLY C 164 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 72 -167.48 -160.08 REMARK 500 VAL A 186 -50.36 -125.71 REMARK 500 SER A 281 38.30 -99.76 REMARK 500 LEU C 66 -1.60 60.98 REMARK 500 TRP C 182 52.13 -92.62 REMARK 500 ASN C 199 58.28 -96.05 REMARK 500 GLN C 236 -4.35 61.64 REMARK 500 ASN C 265 31.53 -99.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 VAL C 152 -12.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-64176 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE HUMAN ADENOSINE A2A RECEPTOR IN LIGAND REMARK 900 FREE STATE RESOLVED USING THE FUSION/CROSSLINKING STRATEGY DBREF 9UHU A 2 208 UNP P29274 AA2AR_HUMAN 2 208 DBREF 9UHU A 225 318 UNP P29274 AA2AR_HUMAN 225 318 DBREF1 9UHU B 4 198 UNP A0A059PIQ0_AEQVI DBREF2 9UHU B A0A059PIQ0 2 196 DBREF 9UHU C 1 294 PDB 9UHU 9UHU 1 294 SEQADV 9UHU GLY A 1001 UNP P29274 LINKER SEQADV 9UHU HIS A 1002 UNP P29274 LINKER SEQADV 9UHU TYR A 1003 UNP P29274 LINKER SEQADV 9UHU LEU A 1004 UNP P29274 LINKER SEQADV 9UHU SER A 1005 UNP P29274 LINKER SEQADV 9UHU THR A 1006 UNP P29274 LINKER SEQADV 9UHU GLN A 1007 UNP P29274 LINKER SEQADV 9UHU THR A 1008 UNP P29274 LINKER SEQADV 9UHU SER A 1009 UNP P29274 LINKER SEQADV 9UHU LEU A 1010 UNP P29274 LINKER SEQADV 9UHU SER A 1011 UNP P29274 LINKER SEQADV 9UHU LYS A 1012 UNP P29274 LINKER SEQADV 9UHU ASP A 1013 UNP P29274 LINKER SEQADV 9UHU LEU A 1014 UNP P29274 LINKER SEQADV 9UHU ASN A 1015 UNP P29274 LINKER SEQADV 9UHU GLU A 1016 UNP P29274 LINKER SEQADV 9UHU LYS A 1017 UNP P29274 LINKER SEQADV 9UHU ARG A 1018 UNP P29274 LINKER SEQADV 9UHU ASP A 1019 UNP P29274 LINKER SEQADV 9UHU HIS A 1020 UNP P29274 LINKER SEQADV 9UHU MET A 1021 UNP P29274 LINKER SEQADV 9UHU VAL A 1022 UNP P29274 LINKER SEQADV 9UHU LEU A 1023 UNP P29274 LINKER SEQADV 9UHU LEU A 1024 UNP P29274 LINKER SEQADV 9UHU GLU A 1025 UNP P29274 LINKER SEQADV 9UHU PHE A 1026 UNP P29274 LINKER SEQADV 9UHU VAL A 1027 UNP P29274 LINKER SEQADV 9UHU THR A 1028 UNP P29274 LINKER SEQADV 9UHU ALA A 1029 UNP P29274 LINKER SEQADV 9UHU ALA A 1030 UNP P29274 LINKER SEQADV 9UHU GLY A 1031 UNP P29274 LINKER SEQADV 9UHU MET B 1 UNP A0A059PIQ INITIATING METHIONINE SEQADV 9UHU GLY B 2 UNP A0A059PIQ EXPRESSION TAG SEQADV 9UHU THR B 3 UNP A0A059PIQ EXPRESSION TAG SEQADV 9UHU ILE B 18 UNP A0A059PIQ VAL 16 CONFLICT SEQADV 9UHU ARG B 32 UNP A0A059PIQ SER 30 CONFLICT SEQADV 9UHU TYR B 41 UNP A0A059PIQ ASN 39 CONFLICT SEQADV 9UHU CRO B 68 UNP A0A059PIQ THR 65 CONFLICT SEQADV 9UHU B UNP A0A059PIQ TYR 66 DELETION SEQADV 9UHU B UNP A0A059PIQ GLY 67 DELETION SEQADV 9UHU SER B 74 UNP A0A059PIQ ALA 72 CONFLICT SEQADV 9UHU ARG B 82 UNP A0A059PIQ GLN 80 CONFLICT SEQADV 9UHU TYR B 101 UNP A0A059PIQ SER 99 CONFLICT SEQADV 9UHU MET B 155 UNP A0A059PIQ THR 153 CONFLICT SEQADV 9UHU ASN B 160 UNP A0A059PIQ LYS 158 CONFLICT SEQRES 1 A 332 PRO ILE MET GLY SER SER VAL TYR ILE THR VAL GLU LEU SEQRES 2 A 332 ALA ILE ALA VAL LEU ALA ILE LEU GLY ASN VAL LEU VAL SEQRES 3 A 332 CYS TRP ALA VAL TRP LEU ASN SER ASN LEU GLN ASN VAL SEQRES 4 A 332 THR ASN TYR PHE VAL VAL SER LEU ALA ALA ALA ASP ILE SEQRES 5 A 332 ALA VAL GLY VAL LEU ALA ILE PRO PHE ALA ILE THR ILE SEQRES 6 A 332 SER THR GLY PHE CYS ALA ALA CYS HIS GLY CYS LEU PHE SEQRES 7 A 332 ILE ALA CYS PHE VAL LEU VAL LEU THR GLN SER SER ILE SEQRES 8 A 332 PHE SER LEU LEU ALA ILE ALA ILE ASP ARG TYR ILE ALA SEQRES 9 A 332 ILE ARG ILE PRO LEU ARG TYR ASN GLY LEU VAL THR GLY SEQRES 10 A 332 THR ARG ALA LYS GLY ILE ILE ALA ILE CYS TRP VAL LEU SEQRES 11 A 332 SER PHE ALA ILE GLY LEU THR PRO MET LEU GLY TRP ASN SEQRES 12 A 332 ASN CYS GLY GLN PRO LYS GLU GLY LYS ASN HIS SER GLN SEQRES 13 A 332 GLY CYS GLY GLU GLY GLN VAL ALA CYS LEU PHE GLU ASP SEQRES 14 A 332 VAL VAL PRO MET ASN TYR MET VAL TYR PHE ASN PHE PHE SEQRES 15 A 332 ALA CYS VAL LEU VAL PRO LEU LEU LEU MET LEU GLY VAL SEQRES 16 A 332 TYR LEU ARG ILE PHE LEU ALA ALA ARG ARG GLN LEU GLY SEQRES 17 A 332 HIS TYR LEU SER THR GLN THR SER LEU SER LYS ASP LEU SEQRES 18 A 332 ASN GLU LYS ARG ASP HIS MET VAL LEU LEU GLU PHE VAL SEQRES 19 A 332 THR ALA ALA GLY LEU GLN LYS GLU VAL HIS ALA ALA LYS SEQRES 20 A 332 SER LEU ALA ILE ILE VAL GLY LEU PHE ALA LEU CYS TRP SEQRES 21 A 332 LEU PRO LEU HIS ILE ILE ASN CYS PHE THR PHE PHE CYS SEQRES 22 A 332 PRO ASP CYS SER HIS ALA PRO LEU TRP LEU MET TYR LEU SEQRES 23 A 332 ALA ILE VAL LEU SER HIS THR ASN SER VAL VAL ASN PRO SEQRES 24 A 332 PHE ILE TYR ALA TYR ARG ILE ARG GLU PHE ARG GLN THR SEQRES 25 A 332 PHE ARG LYS ILE ILE ARG SER HIS VAL LEU ARG GLN GLN SEQRES 26 A 332 GLU PRO PHE LYS ALA ALA GLY SEQRES 1 B 196 MET GLY THR ARG LYS GLY GLU GLU LEU PHE THR GLY VAL SEQRES 2 B 196 VAL PRO ILE LEU ILE GLU LEU ASP GLY ASP VAL ASN GLY SEQRES 3 B 196 HIS LYS PHE SER VAL ARG GLY GLU GLY GLU GLY ASP ALA SEQRES 4 B 196 THR TYR GLY LYS LEU THR LEU LYS PHE ILE CYS THR THR SEQRES 5 B 196 GLY LYS LEU PRO VAL PRO TRP PRO THR LEU VAL THR THR SEQRES 6 B 196 LEU CRO VAL GLN CYS PHE SER ARG TYR PRO ASP HIS MET SEQRES 7 B 196 LYS ARG HIS ASP PHE PHE LYS SER ALA MET PRO GLU GLY SEQRES 8 B 196 TYR VAL GLN GLU ARG THR ILE TYR PHE LYS ASP ASP GLY SEQRES 9 B 196 THR TYR LYS THR ARG ALA GLU VAL LYS PHE GLU GLY ASP SEQRES 10 B 196 THR LEU VAL ASN ARG ILE GLU LEU LYS GLY ILE ASP PHE SEQRES 11 B 196 LYS GLU ASP GLY ASN ILE LEU GLY HIS LYS LEU GLU TYR SEQRES 12 B 196 ASN PHE ASN SER HIS ASN VAL TYR ILE MET ALA ASP LYS SEQRES 13 B 196 GLN ASN ASN GLY ILE LYS ALA ASN PHE LYS ILE ARG HIS SEQRES 14 B 196 ASN VAL GLU ASP GLY SER VAL GLN LEU ALA ASP HIS TYR SEQRES 15 B 196 GLN GLN ASN THR PRO ILE GLY ASP GLY PRO VAL LEU LEU SEQRES 16 B 196 PRO SEQRES 1 C 294 ASP LEU GLY LYS LYS LEU LEU GLU ALA ALA ARG ALA GLY SEQRES 2 C 294 GLN ASP ASP GLU VAL ARG ILE LEU MET ALA ASN GLY ALA SEQRES 3 C 294 ASP VAL ASN ALA ALA ASP ASP VAL GLY VAL THR PRO LEU SEQRES 4 C 294 HIS LEU ALA ALA GLN ARG GLY HIS LEU GLU ILE VAL GLU SEQRES 5 C 294 VAL LEU LEU LYS TYR GLY ALA ASP VAL ASN ALA ALA ASP SEQRES 6 C 294 LEU TRP GLY GLN THR PRO LEU HIS LEU ALA ALA THR ALA SEQRES 7 C 294 GLY HIS LEU GLU ILE VAL GLU VAL LEU LEU LYS ASN GLY SEQRES 8 C 294 ALA ASP VAL ASN ALA ARG ASP ASN ILE GLY HIS THR PRO SEQRES 9 C 294 LEU HIS LEU ALA ALA TRP ALA GLY HIS LEU GLU ILE VAL SEQRES 10 C 294 GLU VAL LEU LEU LYS TYR GLY ALA ASP VAL ASN ALA GLN SEQRES 11 C 294 ASP LYS PHE GLY LYS THR PRO PHE ASP LEU ALA ILE ASP SEQRES 12 C 294 ASN GLY ASN GLU ASP ILE ALA GLU VAL LEU GLN LYS ALA SEQRES 13 C 294 ALA GLY GLY GLY SER GLY GLY GLY ASP VAL ASN ALA TYR SEQRES 14 C 294 ASP GLU VAL GLY TRP THR PRO LEU HIS LYS ALA ALA TRP SEQRES 15 C 294 GLY HIS LEU GLU LYS VAL GLU ASP LEU LEU LYS ASN GLY SEQRES 16 C 294 ALA ASP VAL ASN ALA ALA ASP ILE ASP GLY TYR THR PRO SEQRES 17 C 294 LEU HIS LEU ALA ALA PHE SER GLY HIS LEU GLU ILE VAL SEQRES 18 C 294 GLU VAL LEU LEU LYS TYR GLY ALA ASP VAL ASN ALA ASP SEQRES 19 C 294 ASP GLN ALA GLY PHE THR PRO LEU HIS LEU ALA ALA ILE SEQRES 20 C 294 PHE GLY HIS LEU GLU ILE VAL GLU VAL LEU LEU LYS ASN SEQRES 21 C 294 GLY ALA ASP VAL ASN ALA GLN ASP LYS PHE GLY LYS THR SEQRES 22 C 294 PRO PHE ASP LEU ALA ILE ASP ASN GLY ASN GLU ASP ILE SEQRES 23 C 294 ALA GLU VAL LEU GLN LYS ALA ALA MODRES 9UHU CRO B 68 THR CHROMOPHORE MODRES 9UHU CRO B 68 TYR CHROMOPHORE MODRES 9UHU CRO B 68 GLY CHROMOPHORE HET CRO B 68 22 HETNAM CRO {2-[(1R,2R)-1-AMINO-2-HYDROXYPROPYL]-4-(4- HETNAM 2 CRO HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1- HETNAM 3 CRO YL}ACETIC ACID HETSYN CRO PEPTIDE DERIVED CHROMOPHORE FORMUL 2 CRO C15 H17 N3 O5 HELIX 1 AA1 SER A 7 ASN A 34 1 28 HELIX 2 AA2 ASN A 39 SER A 67 1 29 HELIX 3 AA3 ALA A 73 ILE A 108 1 36 HELIX 4 AA4 ARG A 111 VAL A 116 1 6 HELIX 5 AA5 THR A 117 THR A 138 1 22 HELIX 6 AA6 THR A 138 TRP A 143 1 6 HELIX 7 AA7 PRO A 173 ASN A 181 1 9 HELIX 8 AA8 VAL A 186 ALA A 203 1 18 HELIX 9 AA9 LYS A 227 CYS A 259 1 33 HELIX 10 AB1 PRO A 266 ASN A 280 1 15 HELIX 11 AB2 VAL A 283 ILE A 292 1 10 HELIX 12 AB3 ILE A 292 HIS A 306 1 15 HELIX 13 AB4 LYS B 5 THR B 11 5 7 HELIX 14 AB5 PRO B 58 VAL B 63 5 6 HELIX 15 AB6 VAL B 70 SER B 74 5 5 HELIX 16 AB7 PRO B 77 HIS B 83 5 7 HELIX 17 AB8 ASP B 84 ALA B 89 1 6 HELIX 18 AB9 LEU C 2 GLY C 13 1 12 HELIX 19 AC1 GLN C 14 ASN C 24 1 11 HELIX 20 AC2 THR C 37 GLY C 46 1 10 HELIX 21 AC3 HIS C 47 TYR C 57 1 11 HELIX 22 AC4 THR C 70 GLY C 79 1 10 HELIX 23 AC5 HIS C 80 ASN C 90 1 11 HELIX 24 AC6 THR C 103 GLY C 112 1 10 HELIX 25 AC7 HIS C 113 GLY C 124 1 12 HELIX 26 AC8 THR C 136 ASP C 143 1 8 HELIX 27 AC9 ASN C 146 ALA C 157 1 12 HELIX 28 AD1 THR C 175 ALA C 181 1 7 HELIX 29 AD2 HIS C 184 GLY C 195 1 12 HELIX 30 AD3 THR C 207 GLY C 216 1 10 HELIX 31 AD4 HIS C 217 TYR C 227 1 11 HELIX 32 AD5 THR C 240 GLY C 249 1 10 HELIX 33 AD6 HIS C 250 ASN C 260 1 11 HELIX 34 AD7 THR C 273 GLY C 282 1 10 HELIX 35 AD8 ASN C 283 ALA C 294 1 12 SHEET 1 AA112 GLY A1001 SER A1011 0 SHEET 2 AA112 HIS A1020 ALA A1030 -1 O ALA A1030 N TYR A1003 SHEET 3 AA112 LYS B 43 CYS B 50 -1 O LEU B 46 N LEU A1023 SHEET 4 AA112 HIS B 27 ASP B 38 -1 N ARG B 32 O ILE B 49 SHEET 5 AA112 VAL B 13 VAL B 24 -1 N ILE B 18 O GLY B 33 SHEET 6 AA112 THR B 120 LYS B 128 1 O LEU B 121 N LEU B 17 SHEET 7 AA112 THR B 107 GLU B 117 -1 N LYS B 115 O VAL B 122 SHEET 8 AA112 TYR B 94 PHE B 102 -1 N GLN B 96 O ALA B 112 SHEET 9 AA112 VAL B 178 PRO B 189 -1 O THR B 188 N VAL B 95 SHEET 10 AA112 GLY B 162 ASN B 172 -1 N HIS B 171 O GLN B 179 SHEET 11 AA112 ASN B 151 ASP B 157 -1 N MET B 155 O LYS B 164 SHEET 12 AA112 GLY A1001 SER A1011 -1 N HIS A1002 O ILE B 154 LINK C LEU B 66 N1 CRO B 68 1555 1555 1.38 LINK C3 CRO B 68 N VAL B 70 1555 1555 1.38 CISPEP 1 MET B 90 PRO B 91 0 2.43 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 2748 2754 CONECT 2754 2748 2755 CONECT 2755 2754 2756 2759 CONECT 2756 2755 2757 2758 CONECT 2757 2756 CONECT 2758 2756 CONECT 2759 2755 2760 2761 CONECT 2760 2759 2764 CONECT 2761 2759 2762 2765 CONECT 2762 2761 2763 2764 CONECT 2763 2762 CONECT 2764 2760 2762 2768 CONECT 2765 2761 2766 CONECT 2766 2765 2767 2776 CONECT 2767 2766 CONECT 2768 2764 2769 CONECT 2769 2768 2770 2771 CONECT 2770 2769 2772 CONECT 2771 2769 2773 CONECT 2772 2770 2774 CONECT 2773 2771 2774 CONECT 2774 2772 2773 2775 CONECT 2775 2774 CONECT 2776 2766 MASTER 197 0 1 35 12 0 0 6 5993 3 24 65 END